PREVALENCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 INFECTIONS IN NIGERIA

被引:23
|
作者
OLALEYE, OD
BERNSTEIN, L
EKWEOZOR, CC
SHENG, ZJ
OMILABU, SA
LI, XY
SULLIVANHALLEY, J
RASHEED, S
机构
[1] UNIV SO CALIF,SCH MED,VIRAL ONCOL & AIDS RES LAB,1840 N SOTO ST,LOS ANGELES,CA 90033
[2] UNIV SO CALIF,SCH MED,DEPT PREVENT MED,LOS ANGELES,CA 90033
[3] UNIV HOSP IBADAN,COLL MED,IBADAN,NIGERIA
来源
JOURNAL OF INFECTIOUS DISEASES | 1993年 / 167卷 / 03期
关键词
D O I
10.1093/infdis/167.3.710
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The prevalence of human immunodeficiency virus (HIV) types 1 and 2 infections in Nigeria was estimated from 3854 serum samples collected at 21 locations from 1985 to 1990. Seventy-eight samples (2.0%) were reactive for HIV-1 and 49 (1.3%) for HIV-2 antibodies; 5 samples were reactive for both viruses. The prevalence of HIV-1 and -2 infections, respectively, was highest among 60 female prostitutes, with 10% and 6.7% positive. For other groups the respective rates of positivity were 4.1% and 3.4% in 610 patients with sexually transmitted diseases, 3.6% and 1.4% in 140 tuberculosis patients, 1.6% and 0.6% of 1253 other medical patients, and 1.2% and 0.9% of 1640 volunteer blood donors. Of 153 health care workers, 1.3% were positive for HIV-1 only. The age group from 20 to 29 years had the highest prevalences of HIV-1 (3.3%) and -2 (2.2%). In Nigeria, antibody prevalence for both viruses appears to have increased > 10-fold between 1986 and 1990.
引用
收藏
页码:710 / 714
页数:5
相关论文
共 50 条
  • [41] NEUROSYPHILIS AND HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 INFECTION
    SAVALL, R
    CABRE, M
    GRIFOL, M
    ARCHIVES OF NEUROLOGY, 1992, 49 (05) : 440 - 440
  • [42] INFECTION BY THE TYPE-2 HUMAN-IMMUNODEFICIENCY-VIRUS IN A PROSTITUTE
    ARMENGOL, P
    VILLENA, MJ
    CABALLERO, E
    JUSTE, C
    MEDICINA CLINICA, 1995, 104 (04): : 156 - 157
  • [43] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TROPISM FOR HUMAN MACROPHAGES
    COLLMAN, R
    PATHOBIOLOGY, 1992, 60 (04) : 213 - 218
  • [44] THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF GENE - THE ROAD FROM AN ACCESSORY TO AN ESSENTIAL ROLE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION
    VOLSKY, DJ
    POTASH, MJ
    SIMM, M
    SOVA, P
    MA, XY
    CHAO, W
    SHAHABUDDIN, M
    TRANSACTING FUNCTIONS OF HUMAN RETROVIRUSES, 1995, 193 : 157 - 168
  • [45] DETECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1 ANTIBODIES BY NEW AUTOMATED MICROPARTICLE ENZYME-IMMUNOASSAY FOR HIV TYPE-1 AND TYPE-2
    MATTER, L
    GERMANN, D
    JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (09) : 2338 - 2341
  • [46] COMPARISON OF INDIRECT IMMUNOFLUORESCENCE AND MEMBRANE FLUORESCENCE ASSAYS FOR THE DIFFERENTIATION OF ANTIBODIES TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2
    GALLO, D
    HOFFMAN, MN
    YEH, ET
    GEORGE, JR
    HANSON, CV
    JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (09) : 2275 - 2278
  • [47] FUNCTIONAL COMPARISON OF THE BASIC DOMAINS OF THE TAT PROTEINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 IN TRANS ACTIVATION
    ELANGOVAN, B
    SUBRAMANIAN, T
    CHINNADURAI, G
    JOURNAL OF VIROLOGY, 1992, 66 (04) : 2031 - 2036
  • [48] LINEAR B-CELL EPITOPES OF THE MAJOR CORE PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2
    JANVIER, B
    ARCHINARD, P
    MANDRAND, B
    GOUDEAU, A
    BARIN, F
    JOURNAL OF VIROLOGY, 1990, 64 (09) : 4258 - 4263
  • [49] 1-(ETHOXYMETHYL)-6-(PHENYLSELENENYL)PYRIMIDINES WITH ACTIVITY AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2
    GOUDGAON, NM
    MCMILLAN, A
    SCHINAZI, RF
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1992, 3 (05): : 263 - 266
  • [50] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 (HIV-2)
    HUGHES, A
    CORRAH, T
    BLOOD REVIEWS, 1990, 4 (03) : 158 - 164